These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12904715)

  • 21. Combination of inhaled nitric oxide and intravenous prostacyclin for successful treatment of severe pulmonary hypertension in a patient with acute respiratory distress syndrome.
    Kuhlen R; Walbert E; Fränkel P; Thaden S; Behrendt W; Rossaint R
    Intensive Care Med; 1999 Jul; 25(7):752-4. PubMed ID: 10470582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bosentan in systemic sclerosis.
    Heresi GA; Minai OA
    Drugs Today (Barc); 2008 Jun; 44(6):415-28. PubMed ID: 18596996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on pharmacotherapy for pulmonary hypertension.
    Prior DL; Adams H; Williams TJ
    Med J Aust; 2016 Sep; 205(6):271-6. PubMed ID: 27627939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute Respiratory Failure in Interstitial Lung Disease Complicated by Pulmonary Hypertension.
    Vahdatpour CA; Darnell ML; Palevsky HI
    Respir Med; 2020 Jan; 161():105825. PubMed ID: 31785507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary hypertension in patients with interstitial lung diseases.
    Ryu JH; Krowka MJ; Pellikka PA; Swanson KL; McGoon MD
    Mayo Clin Proc; 2007 Mar; 82(3):342-50. PubMed ID: 17352370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled prostacyclin for the treatment of pulmonary hypertension after cardiac surgery.
    Lowson SM; Doctor A; Walsh BK; Doorley PA
    Crit Care Med; 2002 Dec; 30(12):2762-4. PubMed ID: 12483070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.
    Olschewski H; Walmrath D; Schermuly R; Ghofrani A; Grimminger F; Seeger W
    Ann Intern Med; 1996 May; 124(9):820-4. PubMed ID: 8610951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined therapy with inhaled nitric oxide and intravenous prostacyclin in an infant with alveolar-capillary dysplasia.
    Parker TA; Ivy DD; Kinsella JP; Torielli F; Ruyle SZ; Thilo EH; Abman SH
    Am J Respir Crit Care Med; 1997 Feb; 155(2):743-6. PubMed ID: 9032222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
    Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
    Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in the treatment of rheumatic interstitial lung disease.
    Vassallo R; Thomas CF
    Curr Opin Rheumatol; 2004 May; 16(3):186-91. PubMed ID: 15103243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery.
    De Wet CJ; Affleck DG; Jacobsohn E; Avidan MS; Tymkew H; Hill LL; Zanaboni PB; Moazami N; Smith JR
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1058-67. PubMed ID: 15052203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary Hypertension in Parenchymal Lung Diseases: Any Future for New Therapies?
    Harari S; Elia D; Humbert M
    Chest; 2018 Jan; 153(1):217-223. PubMed ID: 28629920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent Pulmonary Hypertension Without Underlying Cardiac Disease as a Presentation of Pulmonary Interstitial Glycogenosis.
    Still GG; Li S; Wilson M; Sammut P
    Fetal Pediatr Pathol; 2018 Feb; 37(1):22-26. PubMed ID: 29336713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of nebulised iloprost combined with inhaled nitric oxide and oral sildenafil on lung transplant patients. Therapeutic efficacy in pulmonary hypertension during surgery].
    Rabanal Llevot JM; Cimadevilla Calvo B; Cifrian Martinez JM; Ruisanchez Villar C; Mons Lera R
    Rev Esp Anestesiol Reanim; 2012 Mar; 59(3):142-9. PubMed ID: 22985755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interstitial lung diseases and pulmonary hypertension].
    Hauber HP
    Internist (Berl); 2009 Sep; 50(9):1072, 1074-6, 1078-9. PubMed ID: 19575171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in the treatment of pediatric pulmonary artery hypertension.
    Barst RJ
    Pediatr Clin North Am; 1999 Apr; 46(2):331-45. PubMed ID: 10218078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of pulmonary hypertension.
    Hoeper MM; McLaughlin VV; Dalaan AM; Satoh T; Galiè N
    Lancet Respir Med; 2016 Apr; 4(4):323-36. PubMed ID: 26975811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treprostinil and Clinical Outcome in Pulmonary Hypertension and Interstitial Lung Disease: Is All Clear?
    Carbone RG; Monselise A; Puppo F
    Chest; 2023 Jul; 164(1):e21. PubMed ID: 37423704
    [No Abstract]   [Full Text] [Related]  

  • 39. Endothelin and pulmonary arterial hypertension.
    Braun-Moscovici Y; Nahir AM; Balbir-Gurman A
    Semin Arthritis Rheum; 2004 Aug; 34(1):442-53. PubMed ID: 15305243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recognition and management of pulmonary hypertension.
    Wanstall JC; Jeffery TK
    Drugs; 1998 Dec; 56(6):989-1007. PubMed ID: 9878988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.